SSRM(SSRM)
SSRM
Q3 2026 EPS Estimate
$0.75
Aug 4, 2026 · Reports after close
Revenue Estimate
$522M
FY2026E EPS$4.41
FY2027E EPS$4.98
Analyst Sentiment
Wall St. Consensus
Buy11 analysts·Moderate coverage
64
Score
7 Buy (64%)3 Hold (27%)1 Sell (9%)
Rating Breakdown
Strong Buy
00%
Buy
764%
Hold
327%
Sell
19%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$39.00
+28.8%
Consensus
$39.50
+30.4%
Bull
$40.00
+32.1%
12-Month Target Range11 analysts
$39.00$39.50$40.00
Current $30.28Consensus
Current Price
$30.28
Upside to Consensus
$9.22
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+9.91%
EPS+12.80%
FY2028
Rev-3.54%
EPS-6.13%
FY2029
Rev-12.81%
EPS-16.29%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $2.44B | $2.68B | $2.59B | $2.26B | $1.99B |
| Low | $2.31B | $2.54B | $2.45B | $2.14B | $1.88B |
| High | $2.54B | $2.79B | $2.69B | $2.35B | $2.07B |
| EBITDA Avg | $529M | $581M | $561M | $489M | $430M |
| Low | $501M | $550M | $531M | $463M | $407M |
| High | $551M | $605M | $584M | $509M | $448M |
| EBIT Avg | $178M | $195M | $188M | $164M | $145M |
| Low | $168M | $185M | $178M | $156M | $137M |
| High | $185M | $203M | $196M | $171M | $150M |
| Net Income Avg | $957M | $1.08B | $1.01B | $849M | $581M |
| Low | $744M | $851M | $944M | $790M | $540M |
| High | $1.17B | $1.28B | $1.07B | $894M | $611M |
| EPS Avg | $4.41 | $4.98 | $4.67 | $3.91 | $2.67 |
| Low | $3.43 | $3.92 | $4.35 | $3.64 | $2.49 |
| High | $5.40 | $5.90 | $4.92 | $4.12 | $2.82 |
| Analysts (Rev / EPS) | 3 / 5 | 4 / 3 | 2 / 1 | 3 / 1 | 3 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $631M | $691M | $664M | $650M | $647M | $630M | $650M | $637M |
| Low | $551M | $602M | $579M | $567M | $564M | $550M | $567M | $556M |
| High | $712M | $779M | $749M | $733M | $729M | $711M | $734M | $718M |
| EBITDA Avg | $137M | $150M | $144M | $141M | $140M | $137M | $141M | $138M |
| Low | $119M | $131M | $126M | $123M | $122M | $119M | $123M | $120M |
| High | $154M | $169M | $162M | $159M | $158M | $154M | $159M | $156M |
| EBIT Avg | $46M | $50M | $48M | $47M | $47M | $46M | $47M | $46M |
| Low | $40M | $44M | $42M | $41M | $41M | $40M | $41M | $40M |
| High | $52M | $57M | $55M | $53M | $53M | $52M | $53M | $52M |
| Net Income Avg | $244M | $295M | $246M | $245M | $247M | $246M | $222M | $217M |
| Low | $204M | $246M | $205M | $205M | $206M | $205M | $185M | $181M |
| High | $285M | $344M | $287M | $286M | $288M | $287M | $259M | $253M |
| EPS Avg | $1.12 | $1.35 | $1.13 | $1.13 | $1.14 | $1.13 | $1.02 | $1.00 |
| Low | $0.94 | $1.13 | $0.94 | $0.94 | $0.95 | $0.94 | $0.85 | $0.83 |
| High | $1.31 | $1.58 | $1.32 | $1.31 | $1.32 | $1.32 | $1.19 | $1.16 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |